Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion.

Avery L, Filderman J, Szymczak-Workman AL, Kane LP.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2455-2460. doi: 10.1073/pnas.1712107115. Epub 2018 Feb 20.

PMID:
29463725
2.

LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes.

Zhang Q, Chikina M, Szymczak-Workman AL, Horne W, Kolls JK, Vignali KM, Normolle D, Bettini M, Workman CJ, Vignali DAA.

Sci Immunol. 2017 Mar 31;2(9). pii: eaah4569. doi: 10.1126/sciimmunol.aah4569.

3.

Interleukin-35 Limits Anti-Tumor Immunity.

Turnis ME, Sawant DV, Szymczak-Workman AL, Andrews LP, Delgoffe GM, Yano H, Beres AJ, Vogel P, Workman CJ, Vignali DA.

Immunity. 2016 Feb 16;44(2):316-29. doi: 10.1016/j.immuni.2016.01.013. Epub 2016 Feb 9.

4.

Preferential control of induced regulatory T cell homeostasis via a Bim/Bcl-2 axis.

Wang X, Szymczak-Workman AL, Gravano DM, Workman CJ, Green DR, Vignali DA.

Cell Death Dis. 2012 Feb 9;3:e270. doi: 10.1038/cddis.2012.9.

5.

Verification of 2A peptide cleavage.

Szymczak-Workman AL, Vignali KM, Vignali DA.

Cold Spring Harb Protoc. 2012 Feb 1;2012(2):255-7. doi: 10.1101/pdb.prot067892.

PMID:
22301658
6.

Generation of 2A-linked multicistronic cassettes by recombinant PCR.

Szymczak-Workman AL, Vignali KM, Vignali DA.

Cold Spring Harb Protoc. 2012 Feb 1;2012(2):251-4. doi: 10.1101/pdb.prot067884.

PMID:
22301657
7.

Design and construction of 2A peptide-linked multicistronic vectors.

Szymczak-Workman AL, Vignali KM, Vignali DA.

Cold Spring Harb Protoc. 2012 Feb 1;2012(2):199-204. doi: 10.1101/pdb.ip067876.

PMID:
22301656
8.

The plasticity of regulatory T cell function.

Pillai MR, Collison LW, Wang X, Finkelstein D, Rehg JE, Boyd K, Szymczak-Workman AL, Doggett T, Griffith TS, Ferguson TA, Vignali DA.

J Immunol. 2011 Nov 15;187(10):4987-97. doi: 10.4049/jimmunol.1102173. Epub 2011 Oct 17.

9.

Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways.

Szymczak-Workman AL, Delgoffe GM, Green DR, Vignali DA.

J Immunol. 2011 Nov 1;187(9):4416-20. doi: 10.4049/jimmunol.1100548. Epub 2011 Sep 26.

10.

Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3.

Bettini M, Szymczak-Workman AL, Forbes K, Castellaw AH, Selby M, Pan X, Drake CG, Korman AJ, Vignali DA.

J Immunol. 2011 Oct 1;187(7):3493-8. doi: 10.4049/jimmunol.1100714. Epub 2011 Aug 26.

11.

The development and function of regulatory T cells.

Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA.

Cell Mol Life Sci. 2009 Aug;66(16):2603-22. doi: 10.1007/s00018-009-0026-2. Epub 2009 Apr 24. Review.

12.

Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress.

Szymczak-Workman AL, Workman CJ, Vignali DA.

J Immunol. 2009 May 1;182(9):5188-92. doi: 10.4049/jimmunol.0803123.

13.

The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling.

Tailor P, Tsai S, Shameli A, Serra P, Wang J, Robbins S, Nagata M, Szymczak-Workman AL, Vignali DA, Santamaria P.

J Immunol. 2008 Jul 1;181(1):243-55.

14.

Generation of T-cell receptor retrogenic mice.

Holst J, Szymczak-Workman AL, Vignali KM, Burton AR, Workman CJ, Vignali DA.

Nat Protoc. 2006;1(1):406-17.

PMID:
17406263
15.

A natural structural variant of the mouse TCR beta-chain displays intrinsic receptor function and antigen specificity.

Aublin A, Ciofani M, Willkomm N, Hamrouni A, Szymczak-Workman AL, Takahashi T, Sandjeu Y, Guillaume P, Vignali DA, Michielin O, Zúñiga-Pflücker JC, Maryanski JL.

J Immunol. 2006 Dec 15;177(12):8587-94.

Supplemental Content

Loading ...
Support Center